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ABSTRACT
Objective To evaluate COVID-19 infection and mortality 
disparities in ethnic and racial subgroups in a state- wise 
manner across the USA.
Methods Publicly available data from The COVID 
Tracking Project at The Atlantic were accessed between 
9 September 2020 and 14 September 2020. For each 
state and the District of Columbia, % infection, % death, 
and % population proportion for subgroups of race 
(African American/black (AA/black), Asian, American 
Indian or Alaska Native (AI/AN), and white) and ethnicity 
(Hispanic/Latino, non- Hispanic) were recorded. Crude 
and normalised disparity estimates were generated for 
COVID-19 infection (CDI and NDI) and mortality (CDM 
and NDM), computed as absolute and relative difference 
between % infection or % mortality and % population 
proportion per state. Choropleth map display was created 
as thematic representation proportionate to CDI, NDI, CDM 
and NDM.
Results The Hispanic population had a median of 158% 
higher COVID-19 infection relative to their % population 
proportion (median 158%, IQR 100%–200%). This was 
followed by AA, with 50% higher COVID-19 infection 
relative to their % population proportion (median 50%, 
IQR 25%–100%). The AA population had the most 
disproportionate mortality, with a median of 46% higher 
mortality than the % population proportion (median 46%, 
IQR 18%–66%). Disproportionate impact of COVID-19 
was also seen in AI/AN and Asian populations, with 
100% excess infections than the % population proportion 
seen in nine states for AI/AN and seven states for Asian 
populations. There was no disproportionate impact in the 
white population in any state.
Conclusions There are racial/ethnic disparities in 
COVID-19 infection/mortality, with distinct state- 
wise patterns across the USA based on racial/ethnic 
composition. There were missing and inconsistently 
reported racial/ethnic data in many states. This 
underscores the need for standardised reporting, attention 
to specific regional patterns, adequate resource allocation 
and addressing the underlying social determinants of 
health adversely affecting chronically marginalised groups.
INTRODUCTION
Since January 2020, when the first COVID-
19- positive patient was identified in the USA, 
there have been over 29 million reported 
cases and over 500 000 reported fatalities as 
of date.1 Although COVID-19 can affect all 
ages regardless of medical comorbidities, 
hospitalised patients are more likely to be 
older and demonstrate at least one medical 
comorbidity.2 It has also become increas-
ingly evident that, in addition to traditional 
risk factors, there are widespread racial and 
ethnic disparities in COVID-19 infection and 
mortality rates, with disproportionately higher 
Strengths and limitations of this study
 ► This study provides estimates of racial and ethnic 
disparities in COVID-19 infection and mortality in a 
state- wise manner across the USA.
 ► Crude and normalised disparity estimates were 
generated for COVID-19 infection and mortality, 
computed as absolute and normalised difference 
between % infection or % mortality and % popula-
tion proportion for each racial and ethnic group by 
state.
 ► Choropleth map display was created as thematic 
representation proportionate to the magnitude of 
disparity estimate for each state, providing a com-
prehensive overview of disparities across the nation.
 ► We used publicly available data from The COVID 
Tracking Project, derived from state reporting 
agencies, with inherent limitations related to incon-
sistent and incomplete reporting, particularly affect-
ing the Asian and American Indian/Alaska Native 
populations.
 ► These data lack clinical and sociodemographic in-
formation to precisely understand the impact of 
social determinants of health, age and other risk 
factors on these disparities.
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impact among vulnerable racial and ethnic minority 
populations.3–7 A recent study based on the US Depart-
ment of Veterans Affairs data showed an excess burden 
of SARS- CoV-2 infection in African American/black and 
Hispanic populations that was not entirely explained by 
underlying medical conditions, residence or site of care; 
however, the study did not find disparities in excess 30- day 
mortality across racial and ethnic subgroups.8 This obser-
vation however is not aligned with a prior report from 
the Centers for Disease Control and Prevention, which 
showed poor outcomes in the African American/black 
population with 1.4 times increased risk of hospitalisa-
tion, twice the risk of intensive care unit (ICU) care or 
ventilator support, and 1.36 times increased risk of death 
compared with the white population.9 Gross et al3 found a 
robust association between African American/black race, 
Latinx ethnicity and estimated age- adjusted COVID-19 
mortality. Overall mortality was highest in African Amer-
ican/black, with 1 in 1020 facing death attributed to 
COVID-19, followed by Indigenous Americans, Pacific 
Islanders and Latinos.3 In addition, a study based on 
community- level disparities in urban US counties in 
large metropolitan areas showed excess infections and 
mortality that are not explained by income, bolstering 
the complex causal pathways that culminate into these 
striking disparities.10
Given the racial and ethnic diversity of the US popula-
tion, its variable composition and thus unique challenges 
faced by racial/ethnic minorities in each state, it is imper-
ative to examine the extent of disparities in COVID-19 
infections and mortality by race and ethnicity on a 
national scale in a state- wise manner. Due to low popula-
tion proportion of certain racial/ethnic groups in specific 
states, they are prone to be overlooked in aggregate esti-
mates. Furthermore, racial/ethnic composition of hospi-
talised patients might differ considerably from that of the 
general population. In this context, state- wise analyses 
from national population- based samples are critical for 
adequate resource allocation and targeted policy imple-
mentation for improving health outcomes. Consequently, 
we evaluated the extent of racial and ethnic disparities in 
COVID-19 infection and mortality as a function of racial/
ethnic composition of the general population across all 
US states and the District of Columbia.
MATERIALS AND METHODS
Study design, setting and data source
This is an observational study based on state- reported, 
population- based data on COVID-19 infection and 
mortality compiled by ‘The COVID Tracking Project’. 
The data source used is publicly available through ‘The 
COVID Tracking Project’ between 10 September 2020 
and 14 September 2020 (https:// covidtracking. com/ 
race/ dashboard). The COVID Tracking Project at The 
Atlantic’s data and website content are published under a 
Creative Commons CC BY 4.0 licence (CC BY 4.0).
Participants
The study population comprises individuals who are 
positive for COVID-19 infection or were reported to 
have COVID-19- related mortality based on state- reported 
data as compiled by The COVID Tracking Project. Data 
regarding racial and ethnic composition of populations 
in US states and the District of Columbia in percentage 
were from the US Census Bureau’s 2018 5- year estimates, 
compiled by The COVID Tracking Project. Data around 
the 9 September 2020 and 14 September 2020 reporting 
timelines were used for this study. For each state and the 
District of Columbia, % infection, % death, and % popu-
lation proportion for subgroups of race and ethnicity 
were recorded (online supplemental table 1). The % 
COVID-19 infection or mortality in each group is defined 
as: [number of infection or deaths in each group/total 
number of COVID-19 infections or deaths] × 100.
Race was categorised into African American/black 
(AA/black), Asian, American Indian or Alaska Native 
(AI/AN), and white. Ethnicity was characterised into 
Hispanic/Latino and non- Hispanic.
Please note the following variations in racial and ethnic 
categorisations:
 ► Some states categorise ‘Hispanic or Latino’ ethnicity 
of any race including black population of Hispanic 
ethnicity. All other race categories were defined as 
not Hispanic or Latino. These states are Arizona, 
California, Colorado, Connecticut, Delaware, Florida, 
Georgia, Illinois, Maryland, Massachusetts, Mississippi, 
Nevada, New Hampshire, New Jersey, New Mexico, 
New York, Rhode Island, South Dakota, Texas, Utah, 
Washington and Wyoming.
 ► Some states report ‘Asian’ as a pan- racial category, 
including Asian, Pacific Islander and Native Hawaiian: 
Arizona, Connecticut, Delaware, Michigan, Okla-
homa, Virginia and Wisconsin. Montana classifies the 
AI/AN population as a pan- racial category including 
AI, AN, Pacific Islander and Native Hawaiian. This 
limits the accuracy of comparison with percentage 
population; however, the estimated disparity index 
was generated for these states, given the population 
percentage of Native Hawaiian and Pacific Islanders is 
<1% and not likely to significantly impact the metric.
Inclusion and exclusion criteria
States reporting race and ethnicity data for a minimum 
of 50% or more of their COVID-19 cases and deaths were 
included in the analyses. States that used non- mutually 
exclusive race categories, used or did not specify the 
usage of other for AI/AN and/or Asian population, or 
had numbers that were <1% were excluded from the anal-
yses, as applicable.
Fifty- one states and the District of Columbia provide 
race/ethnicity data for cases and deaths. The following 
exclusions were made, where applicable:
 ► Utah and Wyoming report non- mutually exclusive 
categories for race and ethnicity and hence were 
entirely excluded from the analyses.
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 ► Texas reported race and ethnicity data on less than 
3% of its COVID-19 cases and hence was excluded 
from analyses for COVID-19 cases.
 ► Texas, West Virginia, Florida, Hawaii, Indiana, Mary-
land, New Jersey, Pennsylvania and New York either 
include AI/AN and/or Asian race categories in ‘other’ 
or do not specify if these are included in ‘other’ and 
hence were excluded from the specific analyses on 
these racial groups.
 ► Numbers that are too small for a reliable disparity 
estimation (<1%), including percentage popula-
tion, infection or mortality, were excluded from the 
analyses.
Additional detailed data can be accessed at https://
covidtrackingcom/race/dashboard.
Patient and public involvement
There was no direct patient or public involvement in the 
design and conduct of this study.
Statistical analysis
State- wise crude and normalised disparity estimates were 
generated for COVID-19 infection (CDI and NDI) and 
mortality (CDM and NDM), computed as absolute and 
normalised difference in percentage points between % 
infection or mortality in each racial and ethnic subgroup 
and % population proportion of the same racial/ethnic 
subgroup. Normalised disparity estimate was generated 
to account for differences in population size for racial/
ethnic subgroups. CDI, NDI, CDM and NDM were 
reported as median and IQR. Choropleth map display 
was created as thematic representation proportionate 
to the magnitude of disparity estimate for each state, 
providing a comprehensive overview of disparities across 
the nation. Percentage estimates that make up <1% of 
the state population or COVID-19 cases or mortality were 
excluded from analyses.
RESULTS
Racial/ethnic disparities in COVID-19 infection
COVID-19 infection was disproportionately high in the 
Hispanic, AA/black, AI/AN and Asian populations, 
relative to their population proportion in many states 
(figures 1 and 2).
Overall across the nation, the Hispanic population 
experienced the highest CDI and NDI, followed by the 
AA/black population. The Hispanic population had a 
median CDI of 14% and an IQR of 8%–19%, and the AA/
black population had a median CDI of 5% and an IQR of 
3%–9%. Similarly, both Hispanic and AA/black popula-
tions experienced higher NDI. The Hispanic population 
had a median NDI of 158% and an IQR of 100%–200%, 
in contrast to the AA/black population median NDI of 
50% and IQR of 25%–100%.
The Hispanic population experienced ≥100% NDI in 
35 out of 44 analysed states, while the AA/black popu-
lation experienced ≥100% NDI in 14 states across the 
nation. In contrast, the overall median CDI in the white 
population was −18% and the IQR −23% to −13%, and 
the median NDI was −26% and the IQR −39% to −17%, 
respectively.
Disproportionate impact of COVID-19 was also seen 
in the AI/AN and Asian populations in many states 
(figures 1 and 2), with 100% or more NDI in nine states 
for the AI/AN population and in seven states for the 
Asian population.
Choropleth maps show the most striking disparity 
in COVID-19 infections in the AA/black population in 
the state of Maine, where 22% of the total COVID-19 
Figure 1 Choropleth map showing crude disparity estimates for COVID-19 infections, computed as absolute percentage 
point difference between % COVID-19 infection and % population proportion by ethnic/racial groups across US states and the 
District of Columbia. AA, African American; AI, American Indian; AN, Alaska Native.
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infections were seen in the AA/black population, who 
otherwise only accounts for 1% of the total population 
(figure 1).
Racial/ethnic disparities in COVID-19 mortality
Overall, across all states, the AA/black population had 
the most disproportionately high COVID-19 mortality 
(figures 3 and 4). The AA/black population had a 
CDM median of 5% (IQR: 1%–11%) and an NDM 
median of 46% (IQR: 18%–66%). Hispanic, white, 
AI/AN and Asian populations showed 0 or <0 median 
CDM and NDM. However, some states showed dispar-
ities in mortality even in these subgroups, such as the 
Hispanic population with 17% CDM and 43% NDM 
in Texas, while the AI/AN subgroups had 45% CDM 
and 500% NDM in New Mexico. The Asian population 
had 4% CDM and 50% NDM in Nevada. Choropleth 
map reveals the most striking disparity in COVID-19 
mortality was present in the AI/AN population in the 
states of Montana and New Mexico (figures 3 and 4). In 
Montana, 34% of the total COVID-19 deaths were seen 
in the AI/AN population, who otherwise only accounts 
for 6% of the total population. In New Mexico, 54% 
of the total COVID-19 deaths were seen in the AI/AN 
population, who otherwise only accounts for 9% of the 
total population (figure 4).
Figure 2 Choropleth map showing normalised disparity estimates for COVID-19 infections computed as CDI normalised by 
% population proportion of each ethnic/racial group across US states and the District of Columbia. AA, African American; AI, 
American Indian; AN, Alaska Native; CDI, crude disparity estimates for COVID-19 infection.
Figure 3 Choropleth map showing crude disparity estimates for COVID-19 mortality, computed as absolute percentage point 
difference between % COVID-19- related mortality and % population proportion by ethnic/racial groups across US states and 
the District of Columbia. AA, African American; AI, American Indian; AN, Alaska Native.
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DISCUSSION
We found widespread racial and ethnic disparities in 
COVID-19 infection and mortality. We summarised these 
findings in a state- wise manner across the USA. Our find-
ings are consistent with previous similar reports.3–7 11
Hispanic and AA/black populations were the most 
disproportionately impacted by COVID-19 infections. 
The AA/black population was the most disproportion-
ately affected by COVID-19- related mortality across the 
nation. AI/AN and Asian populations also showed dispro-
portionately higher infection and mortality in some states, 
although this is susceptible to underestimation since 
many states with less than 1% representation for these 
subgroups were excluded from the analyses. In addition, 
the mortality disparity estimates in our study were not 
age- adjusted. This can underestimate the mortality for 
populations that have greater proportion of younger indi-
viduals, as previously shown.3 We also found widespread 
inconsistencies in reporting from state agencies, causing 
missing or incomparable data particularly affecting the 
Asian and AI/AN subgroups.
We do not have specific information on social determi-
nants of health (SDOH) to understand the exact aetiolo-
gies of these disparities. However, based on a vast body of 
prior evidence, SDOH has a significant impact in driving 
these disparities, mediated via the environment, occupa-
tion and access to care, and higher burden of comorbidi-
ties in chronically marginalised populations.12–14
The higher burden of comorbidities is also known to 
adversely impact disease severity in COVID-19.15 Comor-
bidities such as obesity, hypertension and diabetes may 
result in a chronic, proinflammatory state that compounds 
the cytokine release syndrome observed in COVID-19.16 17 
These comorbidities have underlying SDOH predictors, 
related to food insecurity, economic and environmental 
instability, and psychosocial stress, chronically accentu-
ating the chronic allostatic load on racial/ethnic minority 
populations.18 The impact of these factors can be further 
exacerbated by lack of access to quality and timely care in 
these minority population subgroups.6 19 20
Access to healthcare is another determinant of 
these disparities. Often minority populations rely on 
government- funded healthcare facilities for their medical 
needs. Many of these have under- resourced infrastruc-
ture, not equipped to mobilise at an operational scale, 
which is necessary for a rapidly spreading potentially 
lethal infection like COVID-19. This is particularly rele-
vant for the AI/AN population, who relies heavily on 
the Indian Health Service (IHS) to provide medical care 
in tribal reservations, including the Navajo Nation, the 
largest reservation severely impacted by COVID-19. IHS 
facilities are unable to respond to a crisis of this magnitude 
due to limited hospital beds and ICUs. In addition, IHS 
facility may be inaccessible to those in remote areas and 
IHS does not cover care provided by non- IHS providers 
or facilities, a critical factor that was not addressed in the 
funds provided by the The Coronavirus Aid, Relief, and 
Economic Security Act (CARES Act) stimulus bill.5
Communication challenges due to limited English 
proficiency and lower health literacy result in addi-
tional barriers to seeking and adhering to treatment.21–23 
Furthermore, these groups are more likely to be ‘front- 
line workers’ (eg, grocery, public transport or healthcare 
employees) without the flexibility of remote employ-
ment.24 25 It is important to note that socioeconomic 
differences are not a singular explanation for disparities. 
For example, a recent study found use of public trans-
portation as an independent predictor of COVID-19 
disparities even after adjusting for income, poverty rates, 
education, occupation or access to insurance in AA/black 
Figure 4 Choropleth map showing normalised disparity estimates for COVID-19 mortality, computed as CDM normalised by 
% population proportion of each ethnic/racial group across US states and the District of Columbia. AA, African American; AI, 
American Indian; AN, Alaska Native; CDM, crude disparity estimate for COVID-19 mortality.
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and AI/AN populations.26 Commuting to work in public 
transportation and living in crowding households are not 
conducive to physical distancing, which is critical for miti-
gating exposure to a contagious respiratory illness such as 
COVID-19.5–7
Our study has several limitations, mostly stemming from 
inconsistent and incomplete reporting of race/ethnicity 
data. There were inconsistencies in race/ethnic cate-
gorisation across states. The categories were not mutu-
ally exclusive, with overlap between race and ethnicity. 
Many states do not clarify the composition of the cate-
gory labelled as ‘others’, or may include Asian as ‘pan- 
racial’, effectively combining Asian, Pacific Islander and 
Native American subgroups. Some states reported race/
ethnicity data on only a minority of cases at the time of 
data query. This particularly impacted Asian and AI/AN 
populations, highlighting an urgent need for standardi-
sation and complete reporting of racial and ethnic data. 
Some groups, such as AI/AN and Asian populations, had 
low representation in many states (<1%) and had to be 
excluded from analyses. We do not have detailed clinical 
and sociodemographic information to precisely under-
stand the impact of SDOH, age and other risk factors.
Our findings highlight the magnitude and extent of 
COVID-19 disparities across the nation in a state- wise 
manner. This reinforces the need for mitigating inter-
ventions tailored to the needs of states, based on the 
specific regional patterns of COVID-19- related estimated 
disparity. This is key to ensure adequate representation in 
resource allocation and implementation of public health 
policy.
In conclusion, AA/black, Hispanic, AI/AN and 
Asian populations are disproportionately impacted by 
COVID-19 infection and mortality. We provide a state- 
wise summary of COVID-19 disparity estimates across the 
USA, highlighting state- specific patterns of disparities. 
Hispanic and AA/black populations are most dispropor-
tionately impacted by COVID-19. We also observed higher 
infection and mortality in AI/AN and Asians in some 
states. We acknowledge that the assessment of disparities 
in groups such as in AI/AN and Asians can be underes-
timated in states with <1% population representation of 
these groups. Missing and inconsistent reporting of racial 
and ethnic data was seen in many states, particularly 
with AI/AN and Asian populations. This underscores 
the urgent need for standardised complete reporting of 
racial and ethnic data across the nation to facilitate a well- 
informed public health response to this global crisis.
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